Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Isobutylene oxide | HCID 11208 | — |
| Reactant | HCID 86697541 | HCID 86697541 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 71765594 | HCID 71765594 | — |
Reaction Steps
9-[1-(4-Amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-4-azetidin-3-yl-7-chloro-2-methyl-2,3,4,5-tetrahydro-1,4-benzoxazepine-6-carbonitrile trishydrochloride (0.015 g, 0.034 mmol) was dissolved in N,N-dimethylformamide (1.0 mL) and triethylamine (0.025 mL, 0.18 mmol), and 2,2-dimethyloxirane (0.050 g) was added. The reaction was heated to 85° C. stirred for 4 h. The reaction was concentrated in vacuo, and the product was purified without workup by prep HPLC on a C-18 column eluting water:acetonitrile gradient buffered pH 10 to give the title compound as two diastereomers: Peak #1 (Example 54) (0.002 g, 13%): LCMS calculated for C26H34ClN8O2 (M+H)+: m/z=525.2; found: 525.2; Peak #2 (Example 55) (0.002 g 13%): LCMS calculated for C26H34ClN8O2 (M+H)+: m/z=525.2; found: 525.2.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09309251B2 |
|---|
| Source dataset | uspto-grants-2016_04 |
|---|
| ORD ID | ord-b2562c2121cb4768955935db97dca329 |
|---|
| Source note | uspto-grants-2016_04 |
|---|